Medtronic (MDT) had its price target raised by Barclays PLC from $118.00 to $120.00. They now have an "overweight" rating on the stock.
Medtronic (MDT) had its price target lowered by Piper Sandler from $105.00 to $91.00. They now have a "neutral" rating on the stock.
Jim Cramer on Medtronic (MDT): “I Think That Everything They've Been Doing Lately Is Right” [Yahoo! Finance]
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]